Yoichiro Ikeda
Impact in
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
Papers in
-
- Complement system in diseases 6
-
- Renal Diseases and Glomerulopathies 4
- Chronic Kidney Disease and Diabetes 2
- Co-authors
- Masaomi Nangaku (10 shared papers)Reiko Inagi (4 shared papers)Benjamin D. Humphreys (3 shared papers)Takehiko Wada (2 shared papers)Yoko Yoshida (2 shared papers)Hideki Kato (1 shared paper)Takao Ohta (4 shared papers)Tetsuhiro Tanaka (1 shared paper)
- Journals
- American Journal Of Pathology (1 paper)PLoS ONE (1 paper)Journal of Nephrology (1 paper)BMC Nephrology (1 paper)Clinical Transplantation (1 paper)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Yoichiro Ikeda
18 papers receiving 602 citations
Peers
Comparison fields: 5 of 79
- Nephrology 131
- Clinical Biochemistry 74
- Cancer Research 83
- Biochemistry 38
- Immunology 104
Countries citing papers authored by Yoichiro Ikeda
This map shows the geographic impact of Yoichiro Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoichiro Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoichiro Ikeda more than expected).
Fields of papers citing papers by Yoichiro Ikeda
This network shows the impact of papers produced by Yoichiro Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoichiro Ikeda. The network helps show where Yoichiro Ikeda may publish in the future.
Co-authors
The 25 scholars most cited alongside Yoichiro Ikeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 129 | |
| 2 | 2012 | 96 | |
| 3 | 2018 | 74 | |
| 4 | 1992 | 61 | |
| 5 | 2014 | 54 | |
| 6 | 2018 | 48 | |
| 7 | 2011 | 36 | |
| 8 | 1995 | 36 | |
| 9 | 1996 | 21 | |
| 10 | 2021 | 17 | |
| 11 | 2015 | 17 | |
| 12 | 1994 | 9 | |
| 13 | 2022 | 3 | |
| 14 | 2015 | 3 | |
| 15 | 2024 | 1 | |
| 16 | 1996 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2012 | 0 |
About Yoichiro Ikeda
Yoichiro Ikeda is a scholar working on Immunology, Nephrology, Molecular Biology, Surgery and Clinical Biochemistry, having authored 22 papers that have together received 608 indexed citations. Recurring topics across this work include Complement system in diseases (6 papers), Renal Diseases and Glomerulopathies (4 papers), Cholesterol and Lipid Metabolism (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Chronic Kidney Disease and Diabetes (2 papers), Advanced Glycation End Products research (2 papers) and Genetic and Kidney Cyst Diseases (2 papers). The work is most often cited by research in Nephrology (131 citations), Clinical Biochemistry (74 citations), Cancer Research (83 citations), Biochemistry (38 citations) and Immunology (104 citations). Yoichiro Ikeda has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Masaomi Nangaku, Reiko Inagi, Benjamin D. Humphreys, Takehiko Wada, Yoko Yoshida, Hideki Kato, Takao Ohta, Tetsuhiro Tanaka, Omar H. Maarouf and Ichiro Matsuda. Their work appears in journals such as American Journal Of Pathology, PLoS ONE, Journal of Nephrology, BMC Nephrology and Clinical Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.